Pubblicazioni

Autori:

Cordani, Marco; Butera, Giovanna; Dando, I.; Torrens-Mas, M.; Butturini, E.; Pacchiana, R.; Oppici, E.; Cavallini, C.; Gasperini, S.; Tamassia, N.; Nadal-Serrano, M.; Coan, M.; Rossi, D.; Gaidano, G.; Caraglia, M.; Mariotto, S.; Spizzo, R.; Roca, P.; Oliver, J.; Scupoli, M. T.; Donadelli, M.

Titolo:

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells

Anno:

2018

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Formato:

A Stampa

Referee:

Sì

Nome rivista:

British Journal of Cancer

ISSN Rivista:

0007-0920

N° Volume:

119

Intervallo pagine:

994-1008

Parole chiave:

Oncogenes; Tumour-suppressor proteins;

Breve descrizione dei contenuti:

BACKGROUND: The TP53 tumor suppressor gene is the most frequently altered gene in tumors and mutant p53 gain-of-function isoforms actively promote cancer malignancy. METHODS: A panel of wild-type and mutant p53 cancer cell lines of different tissues, including pancreas, breast, skin, and lung were used, as well as chronic lymphocytic leukemia (CLL) patients with different TP53 gene status. The effects of mutant p53 were evaluated by confocal microscopy, reactive oxygen species production assay, immunoblotting, and quantitative reverse transcription polymerase chain reaction after cellular transfection. RESULTS: We demonstrate that oncogenic mutant p53 isoforms are able to inhibit SESN1 expression and consequently the amount of SESN1/AMPK complex, resulting in the downregulation of the AMPK/PGC-1α/UCP2 axis and mitochondrial O2-· production. We also show a correlation between the decrease of reduced thiols with a poorer clinical outcome of CLL patients bearing mutant TP53 gene. The restoration of the mitochondrial uncoupling protein 2 (UCP2) expression, as well as the addition of the radical scavenger N-acetyl-L-cysteine, reversed the oncogenic effects of mutant p53 as cellular hyper-proliferation, antiapoptotic effect, and resistance to drugs. CONCLUSIONS: The inhibition of the SESN1/AMPK/PGC-1α/UCP2 axis contributes to the pro-oxidant and oncogenic effects of mutant p53, suggesting pro-oxidant drugs as a therapeutic approach for cancer patients bearing mutant TP53 gene.

Pagina Web:

https://doi.org/10.1038/s41416-018-0288-2

Id prodotto:

104651

Handle IRIS:

11562/986629

ultima modifica:

28 novembre 2022

Citazione bibliografica:

Cordani, Marco; Butera, Giovanna; Dando, I.; Torrens-Mas, M.; Butturini, E.; Pacchiana, R.; Oppici, E.; Cavallini, C.; Gasperini, S.; Tamassia, N.; Nadal-Serrano, M.; Coan, M.; Rossi, D.; Gaidano, G.; Caraglia, M.; Mariotto, S.; Spizzo, R.; Roca, P.; Oliver, J.; Scupoli, M. T.; Donadelli, M., Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells «British Journal of Cancer» , vol. 119 , 2018 , pp. 994-1008

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo